The opportunities in data-driven medicine are promising: for patients, for the health system and for the economy. The potential of acquisition and IT-supported application of high-dimensional health data in clinical research and healthcare will for sure be leveraged in the coming years. In addition to the medical-biological perspective, a particular hot topic is to build fit-for-purpose IT-infrastructures on European, German and local scales. Key is also to assess and adapt the interplay of data-driven modern medicine with society and individual patients as beneficiaries and donors.
Nearly 300 participants met digitally for this year’s DigiMed Bayern Symposium "Translational Medicine in the Digital Era" on March 16th to 18th. 21 renowned speakers and participants from the international digital health sector presented and discussed about data-driven medicine and its potentials – for patients, for science, for the health system, for the economy and for the society.
The online symposium was delivered in three topic-specific sessions:
DigiMed Bayern Symposium Program (PDF download)
Professor of Medicine and Co-Director Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York City, U.S.A.
Founder-Director of the Research Centre for E-Health Law, University of Augsburg
Professor for Digital Health, Institute for Informatik, Technische Universität München
Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University Munich
Director Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry